Company / SG&A per Share
Collegium Pharmaceutical, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$8.98
FY2025
5-year range
$3.53 / $8.98
FY2021-FY2025
Trend
+34.2%
vs FY2024
Sector context
#19 of 210
Health Care
What the data says
Among 210 Health Care companies, Collegium Pharmaceutical, Inc. is in the bottom 9% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $0.64 in FY2017 to $8.98 in FY2025.
Based on SEC 10-K filings.
8.98 in FY2025 with a 5-year CAGR of +22.3%. Top quartile in the Health Care sector.
Increased from $5.00 to $8.98 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +20.9%
- 5-Year CAGR
- +22.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 210This company $8.98 Sector average $40.71
▼
-77.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 34.2% year-over-year.
- Ranks #19 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.98 | +34.2% |
| FY2024 | $6.69 | +33.9% |
| FY2023 | $5.00 | -1.8% |
| FY2022 | $5.09 | +43.9% |
| FY2021 | $3.53 | +7.5% |
| FY2020 | $3.29 | -6.0% |
| FY2019 | $3.50 | -9.5% |
| FY2018 | $3.87 | +500.0% |
| FY2017 | $0.64 | -83.4% |
| FY2016 | $3.89 | +178.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026